Dr. Yonghong Li 李永红
Chief Physician
Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Prostate cancer surgery, comprehensive management, and benign prostatic hyperplasia treatment. Expertise includes prostate biopsy, robotic-assisted and open surgery, ablation, and managing elevated PSA levels.
Dr. Li is a Chief Physician and PhD supervisor with 21 years of experience in urologic oncology, having performed over 7,000 surgeries. A globally certified da Vinci robotic surgeon, Dr. Li trained at Cleveland Clinic (2012–2013). Roles include Prostate Tumor Ward Director and reviewer for J Urol.
Professional roles
- Standing Committee Member, Asian Society for Cryosurgery
- Member, Prostate Cancer Expert Committee, Chinese Society of Clinical Oncology (CSCO)
- Vice Chair, Urological and Male Genital Tumor Professional Committee, Guangdong Anti-Cancer Association
- Standing Committee Member and Secretary, Robotic Surgery Branch, Guangdong Medical Association
Name order: in Chinese the family name comes first (Li Yonghong). Papers usually list the name as Yonghong Li or Li Y.
Selected publications
94 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Res, 2023 (senior author): Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling. PubMed 37676279
- Eur J Surg Oncol, 2023 (senior author): Clinical value of normal saline injection for expansion of the anterior perirectal space during prostate cryoablation. PubMed 35817633
- Future Oncol, 2022 (first author): Cytoreductive prostate cryoablation and metronomic cyclophosphamide for metastatic hormone-sensitive prostate cancer. PubMed 35440168
- Prostate Cancer Prostatic Dis, 2021 (senior author): Prostate cryoablation combined with androgen deprivation therapy for newly diagnosed metastatic prostate cancer: a propensity score-based study. PubMed 33664457
- BMC Urol, 2021 (senior author): A novel germline BRCA2 mutation in a Chinese patient with prostate cancer sensitive to platinum chemotherapy: a case report. PubMed 34425813
- BMC Cancer, 2021 (senior author): Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone. PubMed 34388965
- Front Genet, 2021 (senior author): CircCA12 Promotes Malignant Process via Sponging miR-1184 and Upregulating RAS Family in Bladder Cancer. PubMed 34234808
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion